期刊文献+

罗丹明-四苯硼钠体系反荧光猝灭法测定盐酸西替利嗪 被引量:1

Determination of Cetirizine Dihydrochloride by Anti-Fluorescence Quenching on Rhodamine B-Sodium Tetraphenylborate System
在线阅读 下载PDF
导出
摘要 四苯硼钠对罗丹明B具有荧光猝灭作用,使荧光信号强度减弱甚至消失,而盐酸西替利嗪对罗丹明B-四苯硼钠体系具有反猝灭作用,又能使该体系荧光信号增强,且荧光信号增强程度与药物浓度成线性关系。该文以491 nm为激发波长,以610 nm作发射波长,测量空白液与试液荧光强度之差ΔF=F1-F0,根据ΔF值与溶液中的盐酸西替利嗪浓度呈正比关系,建立了一种反荧光猝灭测定盐酸西替利嗪新方法,该方法线性回归方程为ΔF=0.727 5cm-2.357,相关系数R为0.997 2,线性范围3.50~129.3 mg.L-1,检出限为1.05 mg.L-1,方法RSD为1.2%。用本方法对不同厂家生产的盐酸西替利嗪片以及盐酸西替利嗪胶囊样品进行测定,测定值与药品标示量基本相符,加标回收率在92%~106%之间。 The sodium tetraphenylboron has the fluorescence quenching effect on rhodamine B,making the fluorescence signal intensity weaken or even disappear.But cetirizine dihydrochloride has the anti-quenching effect on rhodamine B-the fluorescence signal is enhanced,and there was a linear relationship between the fluorescence signal enhancement degree and drug concentrationt.In the present paper,491 and 610 nm were chosen as the excitation and emission wavelength for measurement of the fluorescence intensity difference ΔF=F1-F0 of blank solution and test solution,and according to positive correlation between the value of ΔF and cetirizine hydrochloride concentration of test solution,a new method of anti-fluorescence quenching for the determination of cetirizine hydrochloride was established.The linear regression equation was ΔF=0.727 5m-2.357,correlation coefficient was 0.997 2,linear range was 3.50~129.3 mg·L-1,the detection limit was 1.05 mg·L-1 and RSD was 1.2%.The cetirizine hydrochloride tablets and cetirizine hydrochloride capsules from different manufacturers were determined by this method,the measured values were basically in line with the labeled amount of drugs,and the recovery rate was between 92% and 106%.
出处 《光谱学与光谱分析》 SCIE EI CAS CSCD 北大核心 2011年第6期1596-1600,共5页 Spectroscopy and Spectral Analysis
基金 国家自然科学基金项目(20942005) 广西科技厅科技攻关项目(桂科攻09321054)资助
关键词 盐酸西替利嗪 罗丹明B-四苯硼钠体系 反荧光猝灭法 Cetirizine dihydrochloride Rhodamine Bsodium tetraphenylboron system Anti-fluorescence quenching method
  • 相关文献

参考文献9

二级参考文献11

  • 1陈腾,李世根,苏锡谭.西替利嗪凝胶的制备和质量评价[J].中国医院药学杂志,2005,25(8):740-741. 被引量:2
  • 2田静,李兴德,周莉.盐酸西替利嗪凝胶剂的制备[J].中国药业,2006,15(4):25-26. 被引量:1
  • 3马满玲,郭美华,许世伟.盐酸西替利嗪凝胶的研制及质量控制[J].中国药房,2006,17(7):506-507. 被引量:2
  • 4[2]安登魁主编.药物分析.第3版.北京:人民卫生出版社,1997.166
  • 5Campoli-Richards DM, Buckley MMT, Fitton A. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticarla[J]. Drugs,1990,40(5) :762-781
  • 6Pagliara A,Testa B,Carrupt PA,et al. Molecular properties and pharmacokinetic behavior of cetirizine,a zwitterionic H 1 -receptor antagonist[J].J Med Chen,1998,41 (6) :853-863
  • 7卫生郝郝标准(试行)[S].WS-396(X-316)-98
  • 8BP[S].2004.volume Ⅰ.416
  • 9倪远平,罗毅平.计算机控制技术[M]重庆大学出版社,1997.
  • 10涂植英.过程控制系统[M]机械工业出版社,1983.

共引文献12

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部